Karyopharm Therapeutics | KPTI - القيمة السوقية





القيمة السوقية تغيير تاريخ
AbbVie USD 384.69B 19.14B 2026-03
Abbott USD 178.41B 39.46B 2026-03
Amgen USD 189.89B 13.64B 2026-03
AstraZeneca USD 301.25B 13.1B 2026-03
BioCryst Pharmaceuticals USD 1.66B 64M 2025-12
Bristol-Myers Squibb USD 123.83B 14.02B 2026-03
Eli Lilly USD 869.02B 146.97B 2026-03
Enanta Pharmaceuticals USD 122M 98M 2024-12
GlaxoSmithKline GBP 83.8B 9.44B 2026-03
Incyte USD 18.73B 660M 2026-03
J&J USD 579.15B 78.91B 2026-03
Karyopharm Therapeutics USD 1.12B 989M 2026-07
MacroGenics USD 287M 103M 2026-07
Merck USD 297.1B 35.84B 2026-03
Nektar Therapeutics USD 12.82B 11.96B 2026-07
Novartis USD 307.76B 15.54B 2026-03
Novartis USD 319.89B 31.63B 2026-07
Pfizer USD 153.81B 12.24B 2026-03
Regeneron Pharmaceuticals USD 81.68B 560M 2026-03
Roche Holding CHF 266.34B 55.46B 2025-12
Takeda JPY 9.01T 1.37T 2026-03
Tectonic Therapeutic USD 510M 70M 2026-07
TG Therapeutics USD 5.31B 572M 2026-03
Ultragenyx Pharmaceutical USD 2.06B 159M 2026-03
Xencor USD 893M 200M 2026-03